Published in Mayo Clin Proc on May 01, 1995
Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology (2008) 3.95
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology (2009) 2.23
Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg (2006) 2.03
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. Br J Cancer (2006) 1.35
Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol (2009) 1.32
Cholangiocarcinoma: molecular pathways and therapeutic opportunities. Semin Liver Dis (2014) 1.28
MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology (2011) 1.22
Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery (2009) 1.11
Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma. World J Gastroenterol (2008) 1.09
Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma. Semin Intervent Radiol (2013) 1.08
Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut (2000) 1.08
MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN. Oncotarget (2015) 1.07
A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells. Hepatology (2010) 1.06
Should we deny surgery for malignant hepato-pancreatico-biliary tumors to elderly patients? World J Surg (2005) 1.06
Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma. HPB (Oxford) (2012) 0.98
Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford) (2009) 0.98
Surgery for cholangiocarcinoma: the role of liver transplantation. HPB (Oxford) (2008) 0.97
New insights on cholangiocarcinoma. World J Gastrointest Oncol (2010) 0.94
Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys (2010) 0.93
The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far? J Gastrointest Oncol (2014) 0.93
A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Ann Surg Oncol (2013) 0.93
Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. J Viral Hepat (2010) 0.92
Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma. Gut Liver (2014) 0.92
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres. Eur J Nucl Med Mol Imaging (2011) 0.92
Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer. J Clin Exp Hepatol (2011) 0.89
Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma. Oncotarget (2015) 0.89
Endoscopic stent placement in the palliation of malignant biliary obstruction. Clin Endosc (2011) 0.85
Photodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma. World J Gastrointest Endosc (2010) 0.85
Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line. Oncol Lett (2013) 0.85
Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma. Sci Rep (2015) 0.81
A fatal case of primary basaloid squamous cell carcinoma in the intrahepatic bile ducts. Case Rep Pathol (2014) 0.81
Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index. World J Gastroenterol (2008) 0.81
Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endosc Ultrasound (2013) 0.81
Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection. Parasitol Res (2011) 0.80
Cholangiocarcinoma: a 7-year experience at a single center in Greece. World J Gastroenterol (2008) 0.79
Interleukin-2 gene-encoded stromal cells inhibit the growth of metastatic cholangiocarcinomas. World J Gastroenterol (2006) 0.79
A Case of Common Bile Duct Cancer That Completely Responded to Combination Chemotherapy of Gemcitabine and TS-1. Gut Liver (2013) 0.78
Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry. Dig Dis Sci (2015) 0.78
Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) (2008) 0.78
Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis. World J Gastroenterol (2017) 0.78
A rare cause of dilated bile duct incidentally detected on imaging. BMJ Case Rep (2014) 0.77
Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma. Radiat Oncol (2014) 0.77
Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma. J Cancer Res Clin Oncol (2003) 0.77
A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy. World J Gastroenterol (2009) 0.76
TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma. Biol Res (2015) 0.76
The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine? J Gastrointest Oncol (2016) 0.75
Neurofibroma of the bile duct: a rare cause of obstructive jaundice. Ann R Coll Surg Engl (2013) 0.75
Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. BMC Cancer (2016) 0.75
Recruited metastasis suppressor NM23-H2 attenuates expression and activity of peroxisome proliferator-activated receptor δ (PPARδ) in human cholangiocarcinoma. Dig Liver Dis (2014) 0.75
HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature. BMC Infect Dis (2016) 0.75
Systemic Therapy of Cholangiocarcinoma. Visc Med (2016) 0.75
Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results. J Cancer Res Clin Oncol (2016) 0.75
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med (2000) 10.21
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med (1997) 8.65
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med (1999) 6.84
Biliary tract cancers. N Engl J Med (1999) 6.36
Surgical management of intussusception in the adult. Ann Surg (1981) 5.42
Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc (2000) 4.45
The frequency of carpal tunnel syndrome in computer users at a medical facility. Neurology (2001) 4.44
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25
Complications following pancreaticoduodenectomy. Current management. Arch Surg (1992) 3.94
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Primary venous leiomyosarcoma: a rare but lethal disease. J Vasc Surg (1992) 3.05
Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97
Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum (1997) 2.93
Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: importance of aneurysm size. AJNR Am J Neuroradiol (1994) 2.59
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54
Molecular evolution of inversions in Drosophila pseudoobscura: the amylase gene region. Proc Natl Acad Sci U S A (1991) 2.48
Lung nodule enhancement at CT: multicenter study. Radiology (2000) 2.32
Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer (2000) 2.28
Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review. BJU Int (2003) 2.17
Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg (1997) 2.13
Autologous platelet-rich plasma does not reduce transfusion of homologous blood products in patients undergoing repeat valvular surgery. Anesthesiology (1993) 2.04
What prognostic factors are important in duodenal adenocarcinoma? Arch Surg (2000) 2.03
Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01
Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol (2012) 2.01
Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med (1987) 1.99
The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg (1992) 1.96
Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94
Lung nodule enhancement at CT: prospective findings. Radiology (1996) 1.85
Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg (1995) 1.82
Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol (2001) 1.79
Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology (1995) 1.78
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Ruptured abdominal aortic aneurysms: repair should not be denied. J Vasc Surg (1992) 1.75
Functional constipation and outlet delay: a population-based study. Gastroenterology (1993) 1.74
Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res (1990) 1.72
Neuroendocrine ampullary tumors: spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type. Surgery (1994) 1.72
Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys (1993) 1.71
Replacement of the inferior vena cava for malignancy: an update. J Vasc Surg (2000) 1.66
Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene (2003) 1.63
Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis (1997) 1.60
Spectrum and management of major complications of laparoscopic cholecystectomy. Am J Surg (1993) 1.59
Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal. Cancer (1999) 1.54
Long-term cognitive outcomes following out-of-hospital cardiac arrest: a population-based study. Neurology (2011) 1.51
Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood (2000) 1.50
Radical resection for carcinoma of the ampulla of Vater. Arch Surg (1991) 1.49
Lung nodules: dual-kilovolt peak analysis with CT--multicenter study. Radiology (2000) 1.49
Early gastric cancer. Br J Surg (1992) 1.49
Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography. AJR Am J Roentgenol (1988) 1.48
Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg (2011) 1.48
Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery (1990) 1.47
Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg (1990) 1.45
Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg (2001) 1.45
Early extubation after abdominal aortic reconstruction. J Cardiothorac Vasc Anesth (1998) 1.45
A prospective psychological evaluation of patients with dysphagia of various etiologies. Dysphagia (1996) 1.44
Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis. Ann Surg (1994) 1.42
Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery (1994) 1.41
The role of portosystemic shunts for variceal bleeding in the liver transplantation era. Arch Surg (1994) 1.40
Discriminate value of esophageal symptoms: a study of the initial clinical findings in 499 patients with dysphagia of various causes. Mayo Clin Proc (1993) 1.40
Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm". Mayo Clin Proc (1997) 1.38
Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experience. Mayo Clin Proc (1994) 1.38
Choledochal cysts in adults: clinical management. Surgery (1984) 1.37
Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology (1995) 1.36
Acute fractures and dislocations of the cervical spine in children and adolescents. J Bone Joint Surg Am (1993) 1.35
Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg (1990) 1.34
Impact of functional dyspepsia on quality of life. Dig Dis Sci (1995) 1.33
The modified Fontan operation. An analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution. J Thorac Cardiovasc Surg (1995) 1.32
Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review. Ann Surg Oncol (1994) 1.31
Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum (1989) 1.30
Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg (2001) 1.29
Duodenal carcinoid tumors: how aggressive should we be? J Gastrointest Surg (2002) 1.26
Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol (2001) 1.25
Clinical comparison of difco ESP, Wampole isolator, and Becton Dickinson Septi-Chek aerobic blood culturing systems. J Clin Microbiol (1996) 1.25
Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobiliary Pancreat Surg (1998) 1.24
Metastatic melanoma of the gastrointestinal tract. Results of surgical management. Arch Surg (1991) 1.22
The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med (1994) 1.22
Long-term results of biliary reconstruction after laparoscopic bile duct injuries. Arch Surg (1999) 1.21
Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4. J Urol (2001) 1.20
Treatment of highly symptomatic polycystic liver disease. Preliminary experience with a combined hepatic resection-fenestration procedure. Ann Surg (1990) 1.18
Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc (2001) 1.17
Sigmoid diverticulitis with perforation and generalized peritonitis. Dis Colon Rectum (1985) 1.17
Acute necrotizing pancreatitis: management by planned, staged pancreatic necrosectomy/debridement and delayed primary wound closure over drains. Br J Surg (1991) 1.16
Reduction mammaplasty: an outcome study. Plast Reconstr Surg (1997) 1.15
Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum (1996) 1.15
Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc (1993) 1.15
Fibrolamellar hepatoma. Am J Surg (1985) 1.14
Surgical treatment of adult primary hepatic sarcoma. Br J Surg (2000) 1.13
External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer (1988) 1.13
Pancreatoduodenectomy for chronic pancreatitis: long-term results in 105 patients. Arch Surg (2000) 1.13
Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer (1995) 1.12
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut (2001) 1.12
Temporary elevation of CA 125 after abdominal surgical treatment for benign disease and cancer. Surg Gynecol Obstet (1989) 1.12
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut (2001) 1.11
Postoperative intussusception in the adult: a previously unrecognized entity? Arch Surg (1981) 1.11
Pseudotumor of infancy and congenital muscular torticollis: 170 cases. Laryngoscope (2001) 1.10
Symptoms of 100 patients with electromyographically verified carpal tunnel syndrome. Muscle Nerve (1999) 1.10
Villous tumors of the duodenum: reappraisal of local vs. extended resection. J Gastrointest Surg (2000) 1.09
Chronic pancreatitis. Results of Whipple's resection and total pancreatectomy. Arch Surg (1988) 1.09
Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol (2000) 1.08
Extracorporeal shock-wave lithotripsy and methyl tert-butyl ether for partially calcified gallstones. Gastroenterology (1989) 1.08